Age at time of event: 18 years or older.Device is a combination product.(b)(4).Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
|
It was reported that premature deployment of the stent occurred.Vascular access was obtained via the femoral artery.The 95% stenosed, concentric target lesion was located in the moderately tortuous and moderately calcified, 3mm in diameter mid right coronary artery (rca).After pre-dilatation was performed, a 12 x 3.00 promus premier¿ drug-eluting stent was advanced to treat the lesion.However, during placement of the stent, it was caught by the calcium deposits and could no longer move.The physician deployed the stent where it stopped and missed to cover the lesion.Subsequently, another stent was deployed to cover the lesion and the procedure was completed.No patient complications were reported and the patient's status was stable.
|